Genetics

Yes—genes can influence baseline susceptibility, and environmental and biological factors may affect whether and how symptoms show up. In endometriosis, things like age at first period, menstrual patterns, immune and inflammatory responses, and hormonal signaling are often discussed as potential “triggers” or modifiers of an inherited tendency.

The microbiome is part of this picture because it can interact with inflammation, immune function, and estrogen metabolism, which may contribute to how the disease behaves in different people. While we can’t change inherited risk, we can help you look at your full clinical story and symptom pattern to understand what may be amplifying your pain or progression and what options—including surgery when appropriate—may best fit your goals. If you’d like, our team can review your history and help you plan next steps based on both genetic risk and modifiable factors.

Genetics may change endometriosis treatment by helping us understand the biological pathways that drive pain, inflammation, and lesion behavior. As those pathways become clearer, researchers can develop more targeted, potentially non-hormonal medications designed for specific mechanisms rather than one-size-fits-all symptom control.

In the near term, the biggest impact is likely improved risk stratification and biomarker development—tools that could help predict who is more likely to have endometriosis, how aggressive it may be, or which approaches might be most effective. Most genetics-guided “precision” treatments are still in development, but our team stays closely aligned with this research and can discuss what’s realistic now versus what may be on the horizon when you meet with us.

No—at this time, there isn’t a validated clinical genetic test or polygenic risk score that can diagnose endometriosis or replace a proper medical evaluation. Genetics may help researchers understand risk over time, but it doesn’t reliably confirm or rule out disease in an individual patient today.

In practice, we diagnose and plan care by putting your symptom history together with a focused pelvic exam and targeted imaging when appropriate. High-quality ultrasound and MRI can be especially useful for mapping suspected disease and guiding next steps, and our team can help you understand what testing is most likely to be informative for your specific symptoms and goals.

Yes—endometriosis can run in families. If you have a first-degree relative (like a parent or sibling) with endometriosis, your risk is higher, and research in twins suggests genetics contribute meaningfully to susceptibility.

That said, heredity isn’t destiny: having affected relatives doesn’t guarantee you’ll develop endometriosis, and it doesn’t reliably predict how severe symptoms might be. Many patients we treat have no known family history, so persistent pelvic pain, painful periods, or infertility concerns still deserve a thorough evaluation based on your symptoms and goals—reach out to schedule a consultation with our team.

Genome-wide association studies suggest endometriosis risk is influenced by many common genetic variants, each with a small effect, rather than one single “endometriosis gene.” Signals have been found near genes including WNT4, GREB1, ESR1, FSHB, VEZT, FN1, SYNE1, and IL1A.

Taken together, these findings point to biology involved in hormone signaling and progesterone response, uterine lining changes (decidualization), inflammation/immune activity, and tissue remodeling outside the uterus. Genetics can help explain why endometriosis tends to run in families, but it doesn’t currently replace a clinical evaluation or guide treatment on its own—if you’re concerned about inherited risk or persistent symptoms, our team can help you sort through the next best steps.